Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook

All right, let's uh look at Burke because the results just out. 213 a share included a 7-cent charge uh related to the closing of a a pharma license agreement. Revenue slipped 2% over the prior year.That's the chart I wanted to look at here. Uh it's been I mean at best like a bond uh with a 3.8% yield. Um now a 3.8% yield.that uh obviously when it was at $130 a share was not a uh as big of a yield. This is the problem. You have the one of the greatest drugs in history, but it doesn't last forever.Kruda and ...